The charts for these three stocks show the kinds of curves that investors should really like -- trending upward.
News & Analysis: DexCom
These medical device stocks appear to have what it takes to be long-term winners.
The medical device maker delivered strong revenue and adjusted earnings growth in Q2 thanks to continued popularity of its G6 continuous glucose monitoring system.
DXCM earnings call for the period ending June 30, 2019.
These three medtech companies are at the forefront of diabetes care.
Good news for the company's G6 CGM system translated to a nice gain.
Which stock wins in a one-on-one matchup between these two leaders in continuous glucose monitoring systems?
DXCM earnings call for the period ending March 31, 2019.
Find out why our team of healthcare experts is laser-focused on these diabetes stocks right now.
The Internet of Things is already made up of billions of connected devices and is only expected to exponentially grow in the years ahead. Here's how investors can profit from the trend driving the smart home and industrial revolution.